MAP4K3-TMEM178 Fusion FISH Probe
The MAP4K3-TMEM178 Fusion FISH Probe is used to confirm a fusion of the MAP4K3 and TMEM178 genes. The fusion of the MAP4K3 and TMEM178 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MAP4K3-TMEM178-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MAP4K3-TMEM178-20-AQAQ | 20 (40 μL) | 200 μL |
|
MAP4K3 Gene Summary
This gene encodes a member of the mitogen-activated protein kinase kinase kinase kinase family. The encoded protein activates key effectors in cell signalling, among them c-Jun. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Gene Name: Mitogen-activated Protein Kinase Kinase Kinase Kinase 3
Chromosome: CHR2: 39476421 -39664219
Locus: 2p22.1
Gene Diseases
The MAP4K3 TMEM178 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|